FLT3 and neoplasm: However, fusion with ETS variant transcription factor 6 (ETV6) produces an ETV6/FLT3 oncoprotein fusion that is constitutively active and utilizes Hsp90, a chaperone known to stabilize a number of proteins required for tumor progression [65].